EP
CNMD icon

Essential Partners’s CONMED CNMD Stock Holding History

Essential Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622 Sell
19
-123
-87% -$4.43K ﹤0.01% 2424
2026
Q1 		$5.02K Buy
142
+138
+3,450% +$5.62K ﹤0.01% 1571
2025
Q4 		$162 Buy
+4
New +$174 ﹤0.01% 2468

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Essential Partners's CNMD Position: Q2 2026 in Review

Essential Partners reduced its CONMED (CNMD) stake by 87% in Q2 2026, selling an estimated $4.43K and leaving 19 shares worth $622. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

Essential Partners first reported a position in CNMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.02K in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Essential Partners held 19 shares of CONMED worth $622 as of Q2 2026.
  • Essential Partners sold 123 CONMED shares in Q2 2026, an estimated $4.43K.
  • CONMED made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2424 holding.
  • Essential Partners first reported a position in CONMED in Q4 2025 and has held it in 3 quarters since.
  • Essential Partners's CONMED position peaked at $5.02K in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.